share_log

金斯瑞生物科技：建議（1）授出發行新股份及購回股份的一般授權（2）重選退任董事（3）修訂股份期權計劃（4）修訂二零一九年限制性股份獎勵計劃（5）修訂二零二一年限制性股份獎勵計劃（6）更新計劃授權限額（7）採納服務提供者分項限額（8）修訂現有組織章程大綱及細則及採納經修訂的組織章程大綱及細則及股東周年大會通告

GENSCRIPT BIO: PROPOSALS FOR (1) GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES, (2) RE-ELECTION OF RETIRING DIRECTORS, (3) AMENDMENT OF THE SHARE OPTION SCHEME, (4) AMENDMENT OF THE 2019 RESTRICTED SHARE AWARD SCHEME, (5) AMENDMENT OF THE 2021

Hong Kong Stock Exchange ·  Apr 22 20:31
Summary by Futu AI
金斯瑞生物科技股份有限公司（GENSCRIPT BIO）將於2024年5月17日舉行股東周年大會，會上將審議多項議案，包括審核及採納截至2023年12月31日止年度的財務報表、董事報告及核數師報告，以及重選董事。此外，大會將考慮授予董事發行新股份及購回股份的一般授權，並將對公司的股份期權計劃、2019年及2021年限制性股份獎勵計劃進行修訂。公司亦建議更新計劃授權限額及採納服務提供者分項限額。股東周年大會通告及相關附錄已於2024年4月22日的公司通函中詳細披露，並將在公司網站及聯交所網站公開。
金斯瑞生物科技股份有限公司（GENSCRIPT BIO）將於2024年5月17日舉行股東周年大會，會上將審議多項議案，包括審核及採納截至2023年12月31日止年度的財務報表、董事報告及核數師報告，以及重選董事。此外，大會將考慮授予董事發行新股份及購回股份的一般授權，並將對公司的股份期權計劃、2019年及2021年限制性股份獎勵計劃進行修訂。公司亦建議更新計劃授權限額及採納服務提供者分項限額。股東周年大會通告及相關附錄已於2024年4月22日的公司通函中詳細披露，並將在公司網站及聯交所網站公開。
GENSCRIPT BIO WILL HOLD ITS ANNUAL GENERAL MEETING ON MAY 17, 2024 AT WHICH A NUMBER OF MOTIONS WILL BE CONSIDERED, INCLUDING THE REVIEW AND ADOPTION OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2023, THE DIRECTORS' REPORT AND AUDITOR'S REPORT, AND THE RE-ELECTION OF DIRECTORS. IN ADDITION, THE GENERAL MEETING WILL CONSIDER GRANTING THE DIRECTORS GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES, AS WELL AS AMENDMENTS TO THE COMPANY'S SHARE OPTION SCHEME, THE 2019 AND 2021 RESTRICTED SHARE AWARD SCHEMES. The Company also proposes to update the Program Authorization Limits and Adoption Service Provider Allowance Limits. THE NOTICE OF THE ANNUAL GENERAL MEETING AND THE RELATED APPENDICES HAVE BEEN DISCLOSED IN DETAIL IN THE COMPANY'S CIRCULAR DATED 22 APRIL 2024 AND WILL BE PUBLISHED ON THE COMPANY'S WEBSITE AND ON THE EXCHANGE WEBSITE.
GENSCRIPT BIO WILL HOLD ITS ANNUAL GENERAL MEETING ON MAY 17, 2024 AT WHICH A NUMBER OF MOTIONS WILL BE CONSIDERED, INCLUDING THE REVIEW AND ADOPTION OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2023, THE DIRECTORS' REPORT AND AUDITOR'S REPORT, AND THE RE-ELECTION OF DIRECTORS. IN ADDITION, THE GENERAL MEETING WILL CONSIDER GRANTING THE DIRECTORS GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES, AS WELL AS AMENDMENTS TO THE COMPANY'S SHARE OPTION SCHEME, THE 2019 AND 2021 RESTRICTED SHARE AWARD SCHEMES. The Company also proposes to update the Program Authorization Limits and Adoption Service Provider Allowance Limits. THE NOTICE OF THE ANNUAL GENERAL MEETING AND THE RELATED APPENDICES HAVE BEEN DISCLOSED IN DETAIL IN THE COMPANY'S CIRCULAR DATED 22 APRIL 2024 AND WILL BE PUBLISHED ON THE COMPANY'S WEBSITE AND ON THE EXCHANGE WEBSITE.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.